Global Heparin Market by Analysis of Major Industry Segments 2015 - 2023
The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions of heparin to gain a competitive advantage in the market.
View full press release